Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Crystal Structures of IRAK-4 Kinase in Complex with Inhibitors: A Serine/Threonine Kinase with Tyrosine as a Gatekeeper — Zhong Lin Wang (2006) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Crystal Structures of IRAK-4 Kinase in Complex with Inhibitors: A Serine/Threonine Kinase with Tyrosine as a Gatekeeper
Shared by
Zhong Lin Wang
Beijing Institute of Technology
Crystal Structures of IRAK-4 Kinase in Complex with Inhibitors: A Serine/Threonine Kinase with Tyrosine as a Gatekeeper
Article
2006
en
Authors
+5 more
Zhong Lin Wang
Beijing Institute of Technology
JL
Jun S. Liu
AS
Athena Sudom
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
1998
ZIP Kinase, a Novel Serine/Threonine Kinase Which Mediates Apoptosis
Taro Kawai
,
Makoto Matsumoto
,
Kohsuke Takeda
,
Hideki Sanjo
,
Akira Shizuo
Molecular and Cellular Biology
Article
1999
Duet is a novel serine/threonine kinase with Dbl-Homology (DH) and Pleckstrin-Homology (PH) domains
Taro Kawai
,
Hideki Sanjo
,
Akira Shizuo
Gene
Article
2023
Receptor tyrosine kinase inhibitors in cancer
Nasim Ebrahimi
,
Elmira Fardi
,
Hajarossadat Ghaderi
,
Sahar Palizdar
,
Roya Khorram
,
Reza Vafadar
,
Masoud Ghanaatian
,
Fatemeh Rezaei‐Tazangi
,
Payam Baziyar
,
Amirhossein Ahmadi
,
Michael R Hamblin
,
Amir Reza Aref
Article
2020
Unravelling the unfolding pathway of human Fas-activated serine/threonine kinase induced by urea
Khalid A. Alamry
,
Saurabha Srivastava
,
Mohd Shahbaaz
,
Parvez Κhan
,
Preeti Gupta
,
Sunayana Begum Syed
,
Naved Azum
,
Abdullah Mohamed Asiri
,
Asimul Islam
,
Faizan Ahmad
,
Md. Imtaiyaz Hassan
Preprint
2022
Receptor Tyrosine Kinase Inhibitors in Cancer Immunotherapy
Nasim Ebrahimi
,
Elmira Fardi
,
Hajarossadat Ghaderi
,
Sahar Palizdar
,
Roya Khorram
,
Reza Vafadar
,
Halimeh Mobarak
,
Amirhossein Ahmadi
,
Michael R Hamblin
,
Amir Reza Aref
Discussion(0)
No comments yet. Be the first to comment.